Related references
Note: Only part of the references are listed.Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa
Benoit Pilmis et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Ceftolozane-tazobactam and Fosfomycin for rescue treatment of otogenous meningitis caused by XDR Pseudomonas aeruginosa: Case report and review of the literature
Antonella Frattari et al.
IDCASES (2018)
Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa
Aurelien Dinh et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014
Lindsey M. Weiner et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2016)
Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia
Samuel L. Aitken et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Continuous versus intermittent infusion of cefepime in neurosurgical patients with post-operative intracranial infections
Huawei Huang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
Chonghua Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Cefepime pharmacodynamics in patients with extended spectrum β-lactamase (ESBL) and non-ESBL infections
Su Young Lee et al.
JOURNAL OF INFECTION (2007)
Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Comparative in vitro activity of piperacillin, piperacillin-sulbactam and piperacillin-tazobactam against nosocomial pathogens isolated from intensive care patients
U Frank et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Pharmacodynamics of cefepime in patients with Gram-negative infections
VH Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit
J Albanèse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
